Mancow's Morning Madhouse Speaks with Brad Thompson
Submitted by admin on Thu, 02/25/2010 - 23:00
National Radio talk show personality, Mancow Muller, speaks with Brad Thompson, Oncolytics Biotech CEO on a novel treatment to treat cancer using reoviruses.
1:49:56 - 1:52:03
Market Data
Download
Recent News
- OncoSec President and CEO Contributes to Physicians News Digest
- Multidisciplinary Care for Colorectal Cancer
- Oncolytics Biotech® Inc. Announces Phase 2 Clinical Trial of REOLYSIN® in Combination with Gemcitabine in Pancreatic Cancer Reaches Primary Endpoint
- Oncolytics Biotech® Inc. Announces Start of Conformity Testing with SAFC®
- Oncolytics Biotech® Inc. Collaborators to Present Positive Phase 2 REOLYSIN Clinical Data in Pancreatic Cancer at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
- Oncolytics Biotech® Inc. Announces Positive Results of U.S. Phase 2 Clinical Trial Investigating REOLYSIN® in Combination with Paclitaxel and Carboplatin in Head and Neck Cancers
- Oncolytics Biotech® Inc. Announces Third Quarter 2011 Results
- Oncolytics Biotech Announces Appointments to Senior Management Team
- Oncolytics Biotech® Inc. to Host Conference Call to Discuss Clinical Data Being Presented at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
- Oncolytics Biotech® Inc. to Present at the JMP Securities Healthcare Conference
- Healing Viruses
- Oncolytics Biotech® Inc. to Present at the Wedbush 2011 Life Sciences Management Access Conference
- The Future of Cancer Clinical Trials Hold Promise Thanks To Viruses
- Oncolytics Biotech® Inc. to Present at 31st Canaccord Genuity Growth Conference
- Oncolytics Biotech® Inc. Announces Publication of Preclinical Research on Synergistic Combination of Chemotherapy with Oncolytic Virotherapy
Contacts & RSS
Investor Relations
Erika Moran
Public Relations
Janet Vasquez
Phone
212.825.3210
